<DOC>
	<DOCNO>NCT01398384</DOCNO>
	<brief_summary>The purpose study determine effect Nitric Oxide Inhalation Myocardial Infarction Size .</brief_summary>
	<brief_title>Effects Nitric Oxide Inhalation Myocardial Infarction Size</brief_title>
	<detailed_description>The primary objective trial ass whether inhaled nitric oxide decrease myocardial infarction ( MI ) size fraction leave ventricular size 48-72 hour patient present ST segment elevation MI undergo successful percutaneous coronary intervention .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>1 . Acute myocardial infarction ( defined episode chest pain related symptom last great 2 hour less 12 hour electrocardiographic evidence ST elevation ( measure 0.08 second J point ; sum great equal 0.6 mV lead I , II , III , AVL , AVF , V1V6 ) . 2 . No evidence congestive heart failure ( S3 evidence pulmonary edema ) normal oxygen saturation â‰¤ 2L oxygen NC . 3 . All patient must undergo successful percutaneous coronary intervention TIMI 0 1 coronary flow result TIMI 2 3 ( residual stenosis le 30 % stented less 50 % open balloon angioplasty ) . 4 . Age &gt; 18 year . 5 . Signed EC approve informed consent . 1 . Prior myocardial infarction ( determined patient history and/or ECG ) , cardiac surgery , severe pericardial , congenital , cardiomyopathic valvular heart disease . 2 . Requirement urgent cardiac surgery . 3 . Previous CABG PCI . 4 . Left bundle branch block . 5 . Unable tolerate magnetic resonance imaging ( include disallow metallic implant BMI &gt; 35 ) unable tolerate gadolinium contrast medium , include patient calculated creatinine clearance le 60 ml/min/1.73 m2 BSA . 6 . Active recent hemorrhage require invasive procedure evaluation transfusion within 6 week prior presentation hemorrhagic stroke within 6 week prior presentation . 7 . Known suspected aortic dissection . 8 . Prior history pulmonary disease require chronic oxygen therapy . 9 . Pregnancy , lactate woman childbearing potential . 10 . Use investigational drug device within 30 day prior enrollment study . Investigational us approve therapy allow . 11 . Medical problem likely preclude completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>ST Elevation MI</keyword>
	<keyword>STEMI</keyword>
</DOC>